• Flora Growth recently expanded into Mexico and Spain with its Mind Naturals and Awe CBD skincare brands
• Additionally, the company ventured into the dry herb market through Vessel brand, its wholly owned subsidiary
• The recent licensing agreement with Tonino Lamborghini marks Flora Growth’s aggressive product diversification plan that has defined its 2021 calendar year
• All the decisions and moves made by the company so far have been geared toward growing the company’s market share, expanding its market reach, and increasing value for its shareholders

Flora Growth (NASDAQ: FLGC) completed its first traditional cannabis Initial Public Offering (“IPO”) in May 2021. Within seven months, the company has embarked on an aggressive market expansion and product diversification plan geared toward stamping its position within the cannabis brand space and creating value for its shareholders. Its latest move was expanding into Mexico and Spain with its Mind Naturals and Awe CBD skincare brands (https://ibn.fm/i5Tez). These products, targeted toward younger consumers and the prestige market respectively, incorporate present-day consumers’ expectations by focusing on high-quality products with natural ingredients. They also represent what the company stands for, specifically regarding environmental conservation and the prioritization of social responsibility. Flora Growth has also introduced new product offerings, evidenced by Vessel Brand’s entry into the dry herb market. Vessel Brand, a wholly-owned subsidiary, has made an aggressive push to expand into the market with its line of exclusive products including, but not limited to, all-in-one dry herb smoking kits with an inverted lighter (https://ibn.fm/1QLnQ). Vessel Brand’s offerings add to Flora Growth’s line of products, which so far cover cosmetics, food and beverage, and hemp textiles. Additionally, a recent licensing agreement with Tonino Lamborghini, a luxury brand that operates in high-end designer products, beverage, hotel, and real estate segments, marked another significant move in Flora Growth’s diversification plan (https://ibn.fm/1wzmp). This agreement will see Flora Growth produce and distribute Tonino Lamborghini-branded cannabis beverages for the North American and Colombian markets. It complements the definitive agreement with Avaria Health & Beauty Corp., reached in November 2021, to facilitate growth in sales, particularly for the KaLaya brand (https://ibn.fm/Vqznh). Throughout 2021, Flora Growth has made a constant and aggressive push to grow its product line, venture into new markets, and forge healthy partnerships and relationships with key players within the industry in order to attain increased sales and a more significant market share. The efforts have paid off so far, with key additions to the company’s product line and entry into strategic markets in Europe, Mexico, Colombia, and even North America. The strides made so far lay a firm foundation for the company as it moves into the 2022 calendar year, which promises to be bigger and better. Flora Growth’s focus is on a global scale. As it works towards sustaining one of the largest outdoor cultivation facilities in the world, it is also slowly growing its market share, expanding its market reach, and stamping its position as a key player within the global CBD space. For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• Lexaria Bioscience is preparing to file an Investigational New Drug application with the U.S. Food and Drug Administration for its patented technology’s use in treating hypertension (high blood pressure)
• The company has completed multiple studies of the benefits of DehydraTECH(TM), in combination with cannabidiol to combat hypertension conditions and consequentially benefit cardiovascular patients
• Lexaria recently announced that it is nearing completion of a third human study in which the company expects to further explore whether DehydraTECH-CBD successfully treats high pulmonary blood pressure
• A comprehensive six-week human clinical study is expected to begin soon

Lexaria Bioscience (NASDAQ: LEXX) is nearing completion of a human clinical study it believes will further its claims that its patented DehydraTECH(TM) technology works effectively with cannabidiol (“CBD”) as a potential treatment for hypertension, which has further potential implications for cardiovascular disease patients. Lexaria’s DehydraTECH technology works with drug substances which are orally ingested and enhances how they are processed into the blood stream without adverse consequences from the transformation process. The company is continuing to generate positive test data through clinical trials as it works toward an Investigational New Drug (“IND”) application filing with the Food and Drug Administration (“FDA”) (https://ibn.fm/jHXZg). The recently completed human clinical study HYPER-H21-3 enrolled 16 volunteers to study acute pulmonary hypertension, administering a single 300 mg dose of a specific DehydraTECH 2.0 CBD formulation to some of them and comparing their results to placebo performance in the remainder of the volunteers. The study has collected blood samples from the volunteers for analysis and expects to report its findings on blood pressure response soon. In cardiovascular conditions, hypertension, or high blood pressure, can lead to an excess of fluid in the lungs that causes difficulty with breathing when acute reductions in oxygen tension known as hypoxia lead pulmonary blood vessels to constrict and arterial pressure to increase. Lexaria’s announcement notes that CBD’s potential as a novel treatment for the pulmonary blood vessel constriction and, as a consequence, for high pulmonary blood pressure has not been explored sufficiently. HYPER-H21-3 evaluates the effects of exposure to hypoxia on the volunteers treated alternatively with placebo or the DehydraTECH 2.0 CBD formulation. The human study joins two others completed this year despite pandemic condition obstacles. The first noted that some hypertensive volunteers achieved a marked drop in blood pressure when administered a DehydraTECH-CBD formulation, in comparison to a control group using generic CBD as a placebo (https://ibn.fm/m8KwR). The second study found DehydraTECH-formulated CBD reduced arterial stiffness in mild-to-moderate hypertension patients in a blinded, placebo-controlled group (https://ibn.fm/ni2c9). A fourth human study, HYPER-H21-4, will evaluate DehydraTECH-CBD as a treatment for hypertension and arterial stiffness over a six-week period. Arterial stiffness naturally increases with age and is associated with increased mortality from diseases such as diabetes mellitus and kidney disorders, as well as the cardiovascular diseases that are the leading cause of death worldwide (https://ibn.fm/7mOQL). Dr. Vernon V S Bonarjee, the head of the cardiology department at Norway’s Stavanger University Hospital, has noted that measuring arterial stiffness may serve as a predictive indicator for determining treatment for cardiovascular disease, even among otherwise asymptomatic individuals, demonstrating the condition’s significance (https://ibn.fm/X3yzJ). For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Marijuana Company of America, Inc. has been expanding its portfolio in recent months through acquisitions and partnerships designed to enhance the company’s revenue stream
• MCOA’s trademarked hempsmart brand of CBD products has been joined by verticals including marijuana cultivator and distributor VBF Brands, CBD brands distributor cDistro, in-store advertiser VapeTV US, and other industry solutions
• The recent completion of VBF Brands’ acquisition grants MCOA efficiency and sustainable cultivation techniques in its product development
• Efforts to expand the legalization of recreational and medicinal marijuana at the federal level have been gaining steam again, portending significant opportunities for growth in 2022

As the COVID pandemic nears the beginning of its third year as a global health and economic crisis, the persistence of the underlying virus’ ability to make news with its alterations of everyday life activities continues to sew a measure of insecurity into the fabric of society (https://ibn.fm/W48yz). Amid the concerns generated by the virus’ continued infectiousness, the momentum to establish free access to cannabis’ wellness and recreational properties has gained renewed vigor, heralding the potential for sweeping changes in the coming year (https://ibn.fm/LBFPe). “The growing bipartisan momentum for cannabis reform shows that Congress is primed for progress in 2022, and we are closer than ever to bringing our cannabis policies and laws in line with the American people,” Reps. Earl Blumenauer (D-Ore.) and Barbara Lee (D-Calif.) wrote in a recent memo to the Congressional Cannabis Caucus (https://ibn.fm/hd8Yf). The congressional leaders’ comments were further underscored by Tom Rodgers of cannabis lobby Carlyle Consulting, who added, “We’re going to have a huge debate next year on cannabis, and they want to have that debate before the midterms. … Virtually every committee in the Senate will receive a piece of this.” Cannabis acquisition and product brand builder Marijuana Company of America (OTC: MCOA) has been building its portfolio intently in recent months to dramatically expand its revenues in the legalized cannabis sector, positioning the company to take advantage of the rising swell of pro-cannabis sentiment. On Dec. 15, MCOA announced the completion of its VBF Brands, Inc. acquisition, adding a marijuana cultivator and distributor based in the heart of the country’s largest legal cannabis market. “We are especially intrigued with this acquisition because of VBF’s reputation for high-quality clones and its unique use of its growing space,” MCOA CEO Jesus Quintero stated as the transaction was announced (https://ibn.fm/ZRk2h). “The company employs a three-tiered growing system, thereby maximizing the square footage of its Salinas, California, facility. Few growers offer the efficiency of VBF Brands, Inc., which provides greater efficiency and sustainable cultivation techniques to provide growers with access to locally grown, high-quality clones to grow cannabis flower.” The VBF acquisition follows vertical-building efforts by MCOA that include the addition of cannabidiol (“CBD”) brands distributor cDistro to the company’s trademarked hempsmart CBD retail operation as well as partnerships and investments with cannabis industry operations such as Cannabis Global Inc. and Natural Plant Extract. The non-binding letter of intent signed last month with United Kingdom-based advertising company VapeTV Ltd. and online vape retailer Jasleen Enterprises LLC foretells a new in-store advertising brand named VapeTV US, Inc. that will help draw further attention to the company’s retail operation (https://ibn.fm/iOb6R). MCOA has also launched subsidiaries hempsmart Brazil and hempsmart Uruguay as part of its continuing forays into the international market (https://ibn.fm/VCpsf), and announced a shift in its business strategy as it expands into the legalized cannabis tetrahydrocannabinol (“THC”) industry (https://ibn.fm/XNh4B). MCOA’s acquisition of VBF Brands exemplifies its commitment to remain fiscally prudent as the business grows through exposure to the global cannabidiol sector. The acquisition also grants MCOA the option to acquire 51 percent of former VBF owner Sunset Island Group, Inc.’s (OTC: SIGO) new cannabis growth facility, which is significantly larger than the clone facility operated by VBF and is expected to have an annual income after the first year of operations of over $30 million, once the licenses for mass cultivation, manufacturing, and distribution are finalized. For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com. NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• BevCanna Enterprises is a diversified health & wellness beverage company which specializes in providing white-label production and distribution solutions to its various partners
• The company recently entered into a manufacturing and distribution agreement with Averi Health Products, which will see BevCanna market Averi’s diverse range of non-alcoholic, cannabis-infused cocktails
• BevCanna has recently announced tie-ups with Keef Brands as well as with The Tinley Beverage Company to produce and distribute its products within the Canadian territory

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients, has recently announced that the company has entered into an agreement to manufacture and distribute white-label cannabis beverages for Averi Health Products (“Averi”). Averi Health Products is an emerging alternative beverage company founded by Terry Donnelly, former CEO of the award-winning Hill Street Beverage Co. Catering to the rapidly changing consumption preferences of millennials who are increasingly choosing to consume less alcohol than preceding generations, Averi has focused its efforts around creating cannabis and hemp-infused adult beverage options directed at consumers with a discerning palate, who are unwilling to compromise on taste, complexity, sophistication, or social experience. Drawing from a library of over 6,000 flavors, Averi will seek to formulate sophisticated classic cocktails which replicate the flavor profile of some the world’s most traditional and best-selling cocktails, while boasting zero alcohol content. Averi will now seek to introduce its growing portfolio of cannabis-infused beverages into the Canadian market through BevCanna’s unique white-label partnership model, which seeks to provide non-licensed partners with access to the Canadian cannabis market in a seamless and compliant manner. “Averi is a great example of this next generation of beverage creators that are coming to BevCanna to bring its cannabis-infused concepts to life,” said Melise Panetta, President of BevCanna. “Our white-label program gives these brands confidence that its beverages will be produced to the highest quality standards and widely distributed through our extensive Canadian network.” With the global cannabis drinks market set to treble in value by 2024, rising from $1.82 billion at the end of 2020 to $5.8 billion within four years, a range of boutique and global brands have sought to tap the market and capitalize on the stratospheric growth rate witnessed within the sector through the introduction of new CBD-derived beverage products (https://ibn.fm/jC6CO). Through its unique white-label solution that provides robust beverage manufacturing and compliant distribution capabilities in the Canadian recreational cannabis market, BevCanna Enterprises has played a key role in sponsoring the entry of a variety of foreign beverage products into the budding Canadian cannabis-infused beverage market. In early August, BevCanna announced that it had successfully completed the first commercial production run for leading U.S. beverage brand, Keef Brands, with the brand’s cannabis-infused beverages selling out to select provincial distribution boards across Canada (https://ibn.fm/THLip). BevCanna also announced that it had entered into a definitive agreement with The Tinley Beverage Company Inc. (CSE: TNY) (OTCQX: TNYBF) to co-manufacture its award-winning cannabis-infused beverages for the Canadian market, a partnership that will see BevCanna produce and distribute Tinley’s ready to drink product portfolio. For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• The Great Place to Work organization included MINDCURE in its 2021 list of the Best Workplaces Managed by Women
• The company was recognized for its employee-oriented perks and programs, which include flexible working hours, monthly team-building events, and a remote work office stipend
• MINDCURE also participated in the Life Sciences Virtual Investor Conference held on December 16, where executives shared the company’s corporate vision and fielded questions from investors and other attendees

Multiple studies have evidenced that women-led companies tend to perform better and are more likely to have more engaged, inspired, and satisfied employees than male-led firms. A Forbes article summarizing the findings of several of these studies concluded that having more females in executive roles is not only fair, but it is also good for business and employees (https://ibn.fm/lgbXc). The veracity of this conclusion was on display recently when the Great Place to Work(TM), a global authority on building, maintaining, and recognizing high-trust, high-performance workplace culture by leveraging 30 years of research, announced Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (“MINDCURE”) as one of the Best Workplaces Managed by Women in 2021 (https://ibn.fm/AyxqJ). To be eligible, companies must have been Great Place to Work-certified and have a female President and CEO. The Great Place to Work then determined the best companies based on employee responses to its Trust Index Survey. Helmed by Co-Founder, President and CEO Kelsey Ramsden, MINDCURE was recognized for several of its perks and programs. These include flexible working hours that allow employees to improve their mental and physical well-being, monthly team-building events, and a remote work office stipend that assisted employees in setting up a home office. Headquartered in Vancouver, British Columbia, MINDCURE is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health. It comes as no surprise, therefore, that this focus on mental health reflects in the company’s internal operations as seen in the company’s documented perks and programs. In addition to researching psychedelic compounds, which has resulted in the production of synthetic ibogaine, MINDCURE also focuses on developing digital therapeutics (“DTx”) and is, in fact, a member of the Digital Therapeutics Alliance (“DTA”). Elsewhere, MINDCURE participated in the most recent Life Sciences Virtual Investor Conference, a day-long virtual, quarterly event that provides an efficient and unique opportunity for public and private companies to engage with a broader investor base and communicate their strategies. Held on December 16, the event featured live company presentations and interactive discussions. As part of its 30-minute presentation, MINDCURE executives shared the company’s corporate vision and responded to investors’ and other attendees’ questions (https://ibn.fm/F8PJA). Notably, MINDCURE is ideally poised as an attractive investment option for investors interested in investing in psychedelics. This is partly because the company is focused on revolutionizing the mental health industry by researching and developing solutions that prioritize the root causes of mental health issues instead of the conventional symptoms-oriented remedy approach. As such, investors can participate in this revolution as well as propel it forward. So far, the company has begun the production of synthetic ibogaine, a chemically complex psychedelic compound naturally found in plants native to West Africa. Preliminary data demonstrates that ibogaine can be used as a potential treatment for addiction, anxiety disorders and depression, and cognitive enhancement (https://ibn.fm/Pgcxw). Individually, these treatment areas represent significant market opportunities. For instance, the global drug addiction treatment market, which was valued at US$16.47 billion in 2018, is projected to grow at a 7.0% CAGR, reaching US$31.17 billion by 2027 (https://ibn.fm/Nt59D). The anxiety disorders and depression treatment market is projected to expand at a 2.6% CAGR from US$8.5 billion in 2019 to US$13.03 billion by 2027 (https://ibn.fm/YePRl). In addition, researchers at Allied Market Research anticipate that the global cognitive and memory enhancer drugs market will reach $6.6 billion by 2023 from $3.7 billion in 2016, marking a CAGR of 8.6% (https://ibn.fm/UTqM7). Separately, the global DTx market is expected to reach US$13.1 billion by 2026 from US$3.4 billion in 2021, representing a CAGR of 31.4% (https://ibn.fm/ws6FD). To uniquely capitalize on this projected growth, MINDCURE has striven to protect its innovations with provisional patent applications submitted for research and technological advances, as well as maintain a strong financial position. For more information, visit the company’s website at www.MindCure.com. NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF

• PlantX just entered into an asset purchase agreement with Peter Rubi, LLC, to acquire its assets and assume specific liabilities
• This acquisition marks a significant milestone for PlantX and adds to the list of purchases for 2021, which so far includes Bloombox Club, New Deli, Little West, and Locavore
• The move is designed to strengthen PlantX’s e-commerce strategy and expand its market reach in the Midwestern US
• The two Peter Rubi brick-and-mortar stores will be relaunched under the XMarket brand

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) just announced having entered into an asset purchase agreement with Peter Rubi, LLC through PlantX Midwest Inc., a wholly-owned subsidiary. Following the arrangement, PlantX has acquired all of Peter Rubi’s assets and assumed specific liabilities, in exchange for $1.2 million in cash, along with 9,188,897 common shares in an authorized share structure of PlantX, valued at $0.2774 per share (https://ibn.fm/k8zzw). Peter Rubi is a critical player in the plant-based market, specifically in the Chicagoland area. The company has a robust e-commerce platform and two brick-and-mortar stores located in Plainfield and Chicago, Illinois. Known for its plant-based catering services and products that include seasonal fruit and vegetable trays, this company has grown to operate at a yearly revenue run-rate that exceeds $7 million. PlantX is confident that this asset purchase will enhance its overall PlantX e-commerce strategy. It will primarily utilize Peter Rubi’s warehousing facilities, extensive customer base, operational potential, and plant-based merchandising expertise to enhance its fulfilling and distribution capabilities and therefore boost growth within the Midwestern American market. PlantX also plans to involve Peter Rubi founders, who will add to its overall human resources and lend extensive operational experience to establish a sustainable plant-based infrastructure within the United States. “We are extremely proud to welcome Peter Rubi into our growing PlantX family under the increasingly iconic XMarket brand,” noted Sean Dollinger, the founder of PlantX. The two Peter Rubi stores will be relaunched under the XMarket brand. The Illinois stores will also serve as new storage and fulfillment centers that will further diversify PlantX’s distribution capabilities, including assisting with orders through the company’s e-commerce platform. Both locations will also feature the XMarket interactive shopping model designed to help grow PlantX’s brand awareness and spur online customer engagement. This asset purchase agreement, dated December 12, 2021, will also feature the payment of a finder’s fee of 1,029,156 common shares at a deemed issue price of $0.2774, in addition to the cash plus common share for the acquisition. A financial advisory fee to an arm’s length financial advisor will also accompany it to the tune of $18,000 and the issuance of an aggregate of 166,763 common shares. PlantX also announced that it plans to complete a non-brokered private placement of up to $10 million in unsecured convertible debentures. These debentures will be convertible into units of the company at a lesser of 20% discount to the closing market price of common shares on the Canadian Securities Exchange (“CSE”), as well as a maximum permissible discounted price on the conversion date under policies of the CSE. Proceeds from this offering will be used as general working capital. “Building on Peter Rubi’s influential presence in the Chicagoland area, this accretive acquisition gives PlantX access to an impressive new community in and around the third largest city in the US, while solidifying our e-commerce market presence and impact in the Midwestern US,” added Mr. Dollinger. “The new acquisition, alongside our ongoing partnership with Chicago Bears Quarterback Justin Fields, one of America’s most beloved plant-based athletes, demonstrates PlantX’s unique approach to building a sustainable legacy in the US,” he concluded. This move marks a significant milestone for PlantX as it works towards becoming the digital face of the plant-based community with its one-stop-shop for everything plant-based. This Peter Rubi asset acquisition adds to the growing list of PlantX acquisitions for the 2021 calendar year, which so far includes Bloombox Club, New Deli, Little West, and Locavore. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• InnerScope Hearing Technologies’ subsidiary HearingAssist, announced that they had received $277,000 worth of purchase orders from Walmart for their EZ-Hear device
• The EZ-Hear Neckband Bluetooth Hearing Amplifier is a rechargeable Bluetooth hearing amplifier which enables users to combine hearing amplification, hands-free calling and music streaming
• InnerScope completed the acquisition of HearingAssist in late November for a gross consideration of $10 million

InnerScope Hearing Technologies (OTC: INND), a manufacturer and distributer/retailer of DTC, FDA registered, Bluetooth app-controlled hearing aids and personal sound amplifier products (“PSAPs”), as well as various hearing-related products, announced that its recently acquired and wholly-owned subsidiary HearingAssist, had received purchase orders from Walmart totalling over $277,000 for its EZ-Hear Neckband Bluetooth Hearing Amplifier for an in-store display to be located within 757 Walmart stores (https://ibn.fm/cooaH). The EZ-Hear Neckband Bluetooth Hearing Amplifier (“EZ-Hear”) is a fully rechargeable Bluetooth hearing amplifier that combines hearing amplification with easy-to-use hands-free calling and music streaming. HearingAssist recently revealed that it had ramped up its production of the product to meet the demand for in-store Walmart purchases, with the product set to initially be stocked across 5 US states (Texas, North Carolina, Tennessee, Colorado, and Arizona). The company has also stated that it expects to continue receiving and fulfilling additional purchase orders from Walmart for the EZ-Hear Neckband Hearing Amplifiers. The company’s order win comes only a few weeks following the announcement that InnerScope Hearing Technologies had completed the acquisition of Hearing Assist II, LLC (“HearingAssist”) for a gross consideration amounting to $10 million equivalent of InnerScope’s restricted shares of common stock. Following the acquisition, InnerScope Hearing Technologies stated that it expected the acquisition of HearingAssist and the companies’ combined revenue synergies to contribute positively to the former company’s revenues, most immediately through sales generated through HearingAssist’s hearing product kiosk displays located within Walmart stores (https://ibn.fm/zVlf7). Matthew Moore, president and CEO of InnerScope, stated following the acquisition: “Today is a tremendous milestone for InnerScope. I’m delighted to welcome the HearingAssist team, who share our passion for providing convenient and affordable hearing products for the tens of millions of Americans who suffer from hearing loss. The HearingAssist acquisition is another meaningful step in advancing our strategy to grow as a leader and innovator in the direct-to-consumer hearing aid market. Moreover, adding HearingAssist and its management team with their proven track record should continue generating millions of dollars in sales revenues with Walmart in-store displays and Walmart.com and through its online website at http://hearingassist.com/ Since the company’s inception in 2008, HearingAssist has rapidly established themselves as a leader in the direct-to-consumer hearing aid market with over 500,000 hearing aids sold and top-line revenues of more than $72 million since 2018, in the process transforming into Walmart’s largest hearing aid supplier. Following the recent acquisition, the combined InnerScope-HearingAssist management team have sought to further their recent growth momentum, launching an aggressive marketing campaign for the holiday season dedicated to building on HearingAssist’s brand messaging as America’s No. 1 Affordable Hearing Brand, as well as using HearingAssist’s acclaimed national television commercial, which includes a “Free Holiday Special Offer“ valued at $149. For more information, visit the company’s website at www.INND.com and the company’s e-commerce website www.iHeardirect.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• Experts in the cryptocurrency field have made predictions that foresee the value of Bitcoin going over US$100,000 by 2023, with some even seeing us on the brink of higher value jumps by January 2022, making holding and use by the general public more tempting
• The cost and speed of completing transactions has been a problem when conducting business on the traditional blockchain, but the Lightning Network has reduced the fees and wait times for settlement
• LQwD launched its Lightning Network PaaS offering on November 17, aiming to hep more users complete crypto-based transactions instantly, securely, and inexpensively worldwide

The interest in Bitcoin has skyrocketed since the beginning of 2021, making it a hot topic among investors and popular culture. Even U.S. government officials and the Biden administration have expressed interest in new cryptocurrency regulations (https://ibn.fm/u8EkI). It does not matter what the public’s personal opinion is of cryptocurrency – it is becoming more mainstream each day. Recently, El Salvador adopted Bitcoin as the official currency, a move made effective in September with the Bitcoin Law. And companies like LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) are working hard towards increasing Bitcoin adoption, making cryptocurrency transactions faster and more affordable for everyone. The price of Bitcoin depends on the influence of specific economic factors – scarcity, mainstream adoption, regulation, and mining cycles. In recent weeks, the value of Bitcoin fluctuated significantly. With the volatility of Bitcoin remaining high, ease of liquidity and transactions are seen as important in encouraging more usability. Predictions on the value of Bitcoin vary, some being more optimistic than others. Some of the most prominent predictions from well-known investors, evangelists, and public commentators in the cryptocurrency industry include (https://ibn.fm/WRdOo):

• Ian Balina, a Bitcoin investor and founder of the cryptocurrency research and media company Token Metrics, predicts that the value will rise to US$75,000 by the end of 2021. He does not think that $100,000 is out of the question but prefers to keep his prediction on the conservative end of the spectrum.
• Matthew Hyland, technical analysis and blockchain data analyst, predicts a US$250,000 value by January 2022. His prediction is based on historical data. He believes that the US$100,000 threshold is inevitable and cited 2017 when the coin’s value jumped 150% from US$8,000 to US$20,000 just after Thanksgiving.

As Bitcoin is growing in value and popularity, more services emerge to help people make purchases and transactions using the cryptocurrency. Instead of using the traditional blockchain experience for transactions, more people are looking to the Lightning Network, which allows for costs to be lowered and payments to settle much quicker. The Lightning Network is a second-layer technology applied to Bitcoin using micropayment channels to essentially scale the blockchain’s capability and conduct transactions quickly and efficiently. With the Lightning Network, users of Bitcoin can say goodbye to the frustrating “mainchain” experience they often deal with when trying to send, receive, or purchase Bitcoin. Taking the payments off the main blockchain has allowed for transaction costs to be lower and more efficient overall. LQwD FinTech Corp is focused on helping make transactions on the Lightning Network even more cost-effective and efficient. To this end, LQwD launched a platform-as-a-service (PaaS) offering, lqwd.tech, on November 17. The platform is designed to make Lightning Network access simpler and to support more users looking to complete transactions instantly, securely, and inexpensively worldwide. The company has deployed a part of its own Bitcoin holdings to procure additional nodes and provide liquidity for the platform. LQwD expects that the Lightning Network will be a force for change worldwide and become the global monetary exchange of the future. The network has already seen an impressive 205% growth since January 2021 and is anticipated to reach 700 million users by 2030. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• StorEn battery shown in report that analyzes, issues recommendations regarding the sustainability of supply chain of technology critic elements (“TECs”)
• Inclusion of the image is indicative of StorEn’s commitment to sustainability
• The company is currently in the process of a RegA offering with four different investment tiers; each tier offers a different discount and reward

StorEn Technologies, a developer of evolutionary vanadium flow batteries with a disruptive patent-pending, all-vanadium flow battery technology, and its proprietary residential 5kW/30kWh vanadium flow battery was shown in a recent report released by the Scientific and Technical Advisory Panel (“STAP”) (https://ibn.fm/QDwyi). The report is titled “Technology Critical Elements and Their Relevance to the Global Environmental Facility.” The report analyzes and issues recommendations regarding the sustainability of the supply chain of technology critic elements (“TECs”), from green mining to end-of life-processing and recycling. According to the STAP, TECs are metals that are essential in the development of new technologies, such as energy storage, electronic devices, etc. An independent group of scientists, the STAP advises the Global Environment Facility (“GEF”), which was established in 1992, “on the eve of the 1992 Rio Earth Summit.” The group aims to help tackle the world’s most pressing environmental problems in a variety of ways. Since its inception, the GEF has provided an estimated $20.5 billion in grants and mobilized an additional $112 billion in cofinancing for more than 4,800 qualifying projects in 170 countries. Through its Small Grants Programme, the GEF has provided support to almost 24,000 civil society and community initiatives in 133 countries. The GEF works closely with the United Nations Environment Programme (“UNEP”); the two organizations focus on vital environmental challenges. The GEF and UNEP partnership has been involved in more than 1,000 projects and has inspired, informed and guided public policy making in more than 160 countries. Their work is focused on improving the quality of life and sustainability for future generations. An image of StorEn’s residential vanadium flow battery is included in the report. Inclusion of the image is indicative of StorEn’s commitment to sustainability. Producing products with a battery life of 25 years and more than 15K cycles, the company takes pride in offering batteries that meet consumers demand for efficient, durable and cost-effective energy storage, enabling self-consumption of self-produced electricity and the transition toward a carbon-free economy. The company has developed evolutionary vanadium flow batteries. Incubated at the Clean Energy Business Incubator Program (“CEBIP”) within Stony Brook University in New York, the company is building upon the strengths of vanadium flow batteries to revolutionize the world of residential and industrial energy storage. In part, StorEn’s technology has enhanced the electrical efficiency of the stack and energy density of the electrolyte and module, ultimately reducing costs and improving performance. StorEn is currently in the process of a RegA offering with four different investment tiers; each tier offers a different discount and reward (https://ibn.fm/gApbc). With a proprietary product that answers the call for long-lasting, 100% recyclable, safe and affordable energy storage, StorEn and its disruptive, patent-pending, all-vanadium flow battery technology for energy storage holds real promise in a growing market. For more information, visit the company’s website at www.StorEn.tech. NOTE TO INVESTORS: The latest news and updates relating to StorEn Technologies are available in the company’s newsroom at https://ibn.fm/StorEn

• Report forecasts demand for uranium fuel seeing consistent growth
• Increased demand fueled by nuclear energy playing an even larger role in the electricity and energy systems of tomorrow
• As the largest U.S. uranium producer, Energy Fuels holds three of America’s key uranium production centers

The World Nuclear Association’s Annual Nuclear Fuel Report projects that the demand for uranium fuel is set to increase over the next two decades (https://ibn.fm/XNptT). That’s good news for Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading U.S. uranium mining company. “World nuclear generating capacity is set to continue its upward trend with demand for uranium fuel increasing over the period to 2040, according to the projections in the latest edition of World Nuclear Association’s Nuclear Fuel Report,” stated a recent World Nuclear News article. “Uranium resources are more than enough to meet that demand, but intense development of new projects will be needed in the current decade to avoid potential supply disruptions.” The article went on to report that nuclear generation capacity is expected to grow by 2.6% annually, reaching 615 GWe by 2040 in the reference scenario of the organization’s most recent report. “Nuclear power currently generates about 10% of the world’s electricity,” the article observed. “It is expected to play an increasingly important role in future for reasons including its near-zero emissions of carbon dioxide and other pollutants; its on-demand, reliable and secure nature; and its long-term cost-competitiveness. In addition, its ability to produce near zero-carbon heat could help to decarbonize many hard-to-abate sectors of the economy. “Given its unique combination of attributes — reliability, affordability, low-carbon and universal deployability — it is clear that nuclear energy will play an even larger role in the electricity and energy systems of tomorrow,” said World Nuclear association director General Sama Bilbao y León regarding the report. A leading U.S. uranium mining company, supplying U3O8 to major nuclear utilities, Energy Fuels is ideally positioned to make the most of this anticipated growth in the nuclear energy space. The company holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year. The company is also producing rare earth elements at this facility, opening up a new line of business with the potential to drive significant cash flow in the coming years. The company also owns and operates the Nichols Ranch ISR Project, which is a uranium facility in Wyoming that is currently on standby and has a licensed capacity of 2 million pounds of U3O8 per year. Energy Fuels also owns and operates the Alta Mesa ISR Project in Texas, which is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. For more information, visit the company’s website at www.EnergyFuels.com. NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU